Abstract
Background
Treatment for osteonecrosis of the femoral head (ONFH) remains controversial. Current reviews include low-level evidence studies evaluating the treatment of both pre-collapse and collapse stages of the disease.
Questions/Purposes
The purpose of the current study is to systematically review the literature evaluating core decompression (CD) with bone marrow mesenchymal cells (BMMCs), CD alone, and bisphosphonate treatment in pre-collapse ONFH by focusing just on randomized clinical trials (RCTs) reporting functional and radiologic outcomes. We aim to determine if the literature provides evidence supporting any single approach.
Methods
Using PubMed and EMBASE databases, we reviewed the clinical evidence of treatments for pre-collapse ONFH following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Twelve RCTs met the inclusion criteria.
Results
Results showed that CD with BMMCs has lower risk of femoral head collapse when compared to the CD alone excluding hips lost to follow-up (relative risk (RR) [95% CI]:0.25 [0.11, 0.60]; p = 0.002) and when assumed that hips lost to follow-up experienced collapse (RR [95% CI]: 0.11 [0.03, 0.47]; p = 0.003). Neither CD nor bisphosphonate treatments showed lower risk to femoral head collapse when compared to control treatments (p = 0.46 and 0.31, respectively)
Conclusion
Current literature shows that there is a lower risk of femoral head collapse in patients with ONFH treated with CD combined with BMMCs when compared to CD alone; however, there is no robust evidence to determine the effect on functional outcomes. More RCTs assessing new combination therapies and using standardized outcome measures are required.
Similar content being viewed by others
References
Agarwala S, Shah S, Joshi VR. The use of alendronate in the treatment of avascular necrosis of the femoral head: follow-up to eight years. J Bone Joint Surg Br. 2009; 91: 1013-1018.
Agarwala S, Shah SB. Ten-year follow-up of avascular necrosis of femoral head treated with alendronate for 3 years. J Arthroplasty. 2011; 26: 1128-1134.
Agarwala S, Sule A, Pai BU, et al. Study of alendronate in avascular necrosis of bone. J Assoc Physicians India. 2001; 49: 949-950.
Agarwala S, Sule A, Pai BU, et al. Alendronate in the treatment of avascular necrosis of the hip. Rheumatology (Oxford). 2002; 41: 346-347.
Aldridge JM 3rd, Berend KR, Gunneson EE, Urbaniak JR. Free vascularized fibular grafting for the treatment of postcollapse osteonecrosis of the femoral head. Surgical technique. J. bone Jt. surgery. American Vol. 2004;86-A Suppl:87–101.
Anon. ARCO Committee on Terminology and Staging. The ARCO perspective for reaching one uniform staging system of osteonecrosis. In: Schoutens A, Arlet J, Gardeniers JWM, Huges SPF, editors. Bone circulation and vascularization in normal and pathological . Plenum Press. 1993:375–80.
Arlet JFRP. Forage-biopsie de la tete femorale dans l’osteonecrose primitive. Observations histopathologiques portant sur huit foranes. Rev Rhum. 1964; 31: 257-64.
Cardozo JB, Andrade DMS, Santiago MB. The use of bisphosphonate in the treatment of avascular necrosis: a systematic review. Clin Rheumatol. 2008; 27: 685-688.
Chen CH, Chang JK, Lai KA, et al. Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: A two-year multicenter, prospective, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2012; 64: 1572-1578.
Cui Q, Botchwey EA. Emerging ideas: treatment of precollapse osteonecrosis using stem cells and growth factors. Clin Orthop Relat Res. 2011; 469: 2665-2669.
Gangji V, De Maertelaer V, Hauzeur J-P. Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: Five year follow-up of a prospective controlled study. Bone. 2011;49:1005–1009. Available at: doi:10.1016/j.bone.2011.07.032
Giusti A, Hamdy N a T, Dekkers OM, Ramautar SR, Dijkstra S, Papapoulos SE. Atypical fractures and bisphosphonate therapy: A cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features. Bone. 2011;48:966–971. Available at: doi:10.1016/j.bone.2010.12.033
Ha Y-C, Jung WH, Kim J-R, et al. Prediction of collapse in femoral head osteonecrosis: a modified Kerboul method with use of magnetic resonance images. J Bone Joint Surg Am. 2006; 88(Suppl 3): 35-40.
Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res. 2002; 405: 14-23.
Hernigou P, Manicom O, Poignard A. Core decompression with marrow stem cells. Oper Tech Orthop. 2004; 14: 68.
Hernigou P, Poignard A, Manicom O, et al. The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone. J Bone Joint Surq Br. 2005; 87: 896-902.
Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011; 343: d5928.
Hsu SL, Wang CJ, Lee MS, et al. Cocktail therapy for femoral head necrosis of the hip. Arch Orthop Trauma Surg. 2010; 130: 23-29.
Hungerford DS, Jones LC. Asymptomatic osteonecrosis: should it be treated? Clin Orthop Relat Res. 2004; 429: 124-130.
Joaquin JMM-A, Ariana G, Jordan C V, Amelia N, Lane, Moya-Angeler J, Gianakos AL, Villa JC, Ni A, Lane JM. Current concepts on osteonecrosis of the femoral head. World J. Orthop. 2015;6:590. Available at: http://www.wjgnet.com/2218-5836/full/v6/i8/590.htm
Johnson AJ, Mont MA, Tsao AK, et al. Treatment of femoral head osteonecrosis in the United States: 16-year analysis of the Nationwide Inpatient Sample. Clin Orthop Relat Res. 2014; 472: 617-623.
Jones JPJ. Fat embolism and osteonecrosis. Orthop Clin North Am. 1985; 16: 595-633.
Kang P, Pei F, Shen B, et al. Are the results of multiple drilling and alendronate for osteonecrosis of the femoral head better than those of multiple drilling? A pilot study. Joint Bone Spine. 2012; 79: 67-72.
Koo KH, Kim R, Ko GH, et al. Preventing collapse in early osteonecrosis of the femoral head. A randomised clinical trial of core decompression. J Bone Joint Surq Br. 1995; 77: 870-874.
Koo KH, Kim R. Quantifying the extent of osteonecrosis of the femoral head. A new method using MRI. J Bone Joint Surg Br. 1995; 77: 875-880.
Lai KA, Shen WJ, Yang CY, et al. The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. J Bone Joint Surq Am. 2005; 87: 2155-2159.
Lee YK, Ha YC, Cho YJ, et al. Does Zoledronate Prevent Femoral Head Collapse from Osteonecrosis? A Prospective, Randomized, Open-Label, Multicenter Study. J Bone Joint Surq Am. 2015; 97: 1142-1148.
Li X, Xu X, Wu W. Comparison of bone marrow mesenchymal stem cells and core decompression in treatment of osteonecrosis of the femoral head : a meta-analysis. 2014;7:5024–5030.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009; 62: e1-34.
Ma M, Jj C, Rj S, Lc J, Jr L. Nontraumatic Osteonecrosis of the Femoral Head : Where Do We Stand Today ? 2015:1604–1627.
Min BW, Song KS, Cho CH, et al. Untreated asymptomatic hips in patients with osteonecrosis of the femoral head. Clin Orthop Relat Res. 2008; 466: 1087-1092.
Mitchell DG, Rao VM, Dalinka MK, et al. Femoral head avascular necrosis: correlation of MR imaging, radiographic staging, radionuclide imaging, and clinical findings. Radiology. 1987; 162: 709-715.
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010; 8: 336-341.
Mont MA, Carbone JJ, Fairbank AC. Core decompression versus nonoperative management for osteonecrosis of the hip. Clin. Orthop. Relat. Res. 1996:169–178
Mont MA, Marulanda GA, Jones LC, et al. Systematic analysis of classification systems for osteonecrosis of the femoral head. J Bone Joint Surq Am. 2006; 88(Suppl 3): 16-26.
Mont MA, Zywiel MG, Marker DR, et al. The natural history of untreated asymptomatic osteonecrosis of the femoral head: a systematic literature review. J Bone Joint Surg Am. 2010; 92: 2165-2170.
Mwale F, Wang H, Johnson AJ, et al. Abnormal vascular endothelial growth factor expression in mesenchymal stem cells from both osteonecrotic and osteoarthritic hips. Bull NYU Hosp Jt Dis. 2011; 69(Suppl 1): S56-61.
Neumayr LD, Aguilar C, Earles AN, et al. Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease. Results of a multicenter study at a mean of three years after treatment. J Bone Joint Surq Am. 2006; 88: 2573-2582.
Nishii T, Sugano N, Miki H, et al. Does alendronate prevent collapse in osteonecrosis of the femoral head? Clin Orthop Relat Res. 2006; 443: 273-279.
Papakostidis C, Tosounidis TH, Jones E, Peter V. The role of “cell therapy” in osteonecrosis of the femoral head The role of “cell therapy” in osteonecrosis of the femoral head A systematic review of the literature and meta-analysis of 7 studies. 2016;3674.
Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998; 17: 2815-2834.
Phemister DB. Treatment of the necrotic head of the femur in adults. J Bone Joint Surq Am. 1949; 31A: 55-66.
Pinggera. K KWSNAO. Interthrocanteric osteotomy for avascular necrosis of the head of the femur. Survival probability of two different methods. J Bone Jt. Surg Br. 84(6):817–24.
Reis ND, Schwartz O, Militianu D, et al. Hyperbaric oxygen therapy as a treatment for stage-I avascular necrosis of the femoral head. J Bone Joint Surq Br. 2003; 85: 371-375.
Sen RK, Tripathy SK, Aggarwal S, Marwaha N, Sharma RR, Khandelwal N. Early Results of Core Decompression and Autologous Bone Marrow Mononuclear Cells Instillation in Femoral Head Osteonecrosis. A Randomized Control Study. J. Arthroplasty. 2012;27:679–686. Available at: doi:10.1016/j.arth.2011.08.008
Soohoo NF, Vyas S, Manunga J, et al. Cost-effectiveness analysis of core decompression. J Arthroplasty. 2006; 21: 670-681.
Steinberg ME, Larcom PG, Strafford B, Hosick WB, Corces A, Bands RE, Hartman KE. Core decompression with bone grafting for osteonecrosis of the femoral head. Clin. Orthop. Relat. Res. 2001:71–78.
Steinberg ME. Core decompression of the femoral head for avascular necrosis: indications and results. Can J surq. 1995; 38(Suppl 1): S18-24.
Stulberg BN, Davis a W, Bauer TW, et al. Osteonecrosis of the femoral head: A prospective randomized treatment protocol. Clin Orthop Relat Res. 1991; 268: 140-151.
Wang C, Peng J, Lu S. Summary of the various treatments for osteonecrosis of the femoral head by mechanism: A review. Exp Ther Med. 2014; 8: 700-706.
Wang CJ, Wang FS, Yang KD, et al. Treatment of osteonecrosis of the hip: Comparison of extracorporeal shockwave with shockwave and alendronate. Arch Orthop Trauma Surg. 2008; 128: 901-908.
Zalavras CG, Lieberman JR. Osteonecrosis of the femoral head: evaluation and treatment. J Am Acad Orthop Surg. 2014; 22: 455-464.
Zhao D, Cui D, Wang B, Tian F, Guo L, Yang L, Liu B, Yu X. Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone. 2012;50:325–330. Available at: doi:10.1016/j.bone.2011.11.002
Zhao D, Cui D, Wang B, et al. Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone. 2012; 50: 325-330.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Jordan C. Villa, MD, Solomon Husain, BS, Jelle P. van der List, MD, Arianna Gianakos, DO, have declared that they have no conflict of interest. Joseph M. Lane, MD, reports other from Agnovos, Amgen, Bone Therapeutics, SA, Merck, Inc. CollPlant, Inc., Graftys, Kuros, and Lilly, Inc., outside the work.
Human/Animal Rights
This article does not contain any studies with human or animal subjects performed by the any of the authors.
Informed Consent
N/A
Required Author Forms
Disclosure forms provided by the authors are available with the online version of this article.
Rights and permissions
About this article
Cite this article
Villa, J.C., Husain, S., van der List, J.P. et al. Treatment of Pre-Collapse Stages of Osteonecrosis of the Femoral Head: a Systematic Review of Randomized Control Trials. HSS Jrnl 12, 261–271 (2016). https://doi.org/10.1007/s11420-016-9505-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11420-016-9505-9